Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01172
|
|||||
Drug Name |
Lumiracoxib
|
|||||
Synonyms |
2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid; 2-((2-Chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid; 2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid; 2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid; COX 189; COX-189; COX189; Joicela; Lumiracoxib (USAN/INN); Lumiracoxib [USAN:INN]; Novartis brand of lumiracoxib; Prexige; Prexige (Novartis); Prexige (TN)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antiinflammatory Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C15H13ClFNO2
|
|||||
Canonical SMILES |
CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O
|
|||||
InChI |
InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)
|
|||||
InChIKey |
KHPKQFYUPIUARC-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 220991-20-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 293.72 | Topological Polar Surface Area | 49.3 | ||
Heavy Atom Count | 20 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
4.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10251040
, 103562109
, 104084914
, 104430341
, 12015303
, 121362203
, 123043886
, 125345177
, 126628436
, 126645712
, 126669886
, 128383506
, 131305772
, 134338241
, 135106949
, 136948146
, 137001909
, 139667196
, 144162368
, 144207115
, 14898109
, 152034557
, 160661707
, 160661708
, 160964604
, 162009833
, 162169214
, 163108814
, 164786748
, 166237623
, 170465597
, 172659601
, 17397805
, 175610946
, 178100246
, 179150172
, 184545760
, 46227733
, 46506378
, 50069519
, 50070561
, 50071183
, 50126342
, 50146068
, 57347306
, 6889610
, 76715547
, 81041141
, 81145916
, 92718829
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.